Autophagic Network Analysis of the Dual Effect of Sevoflurane on Neurons Associated with GABARAPL1 and 2

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">DB_ID</td><td class="align_center">Name</td><td class="align_center">Groups</td><td class="align_center">Categories</td><td class="align_center">Indication</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">DB01236</td><td class="align_center">Sevoflurane</td><td class="align_center">Approved, vet approved</td><td class="align_center">Anesthetics<br/>Anesthetics, general<br/>Anesthetics, inhalation<br/>Central nervous system agents<br/>Central nervous system depressants<br/>Cytochrome P-450 CYP2A6 substrates<br/>Cytochrome P-450 CYP2B6 substrates<br/>Cytochrome P-450 CYP2E1 substrates<br/>Cytochrome P-450 CYP3A4 substrates<br/>Ethers<br/>Hematologic agents<br/>Hydrocarbons, halogenated<br/>Nervous system<br/>Platelet aggregation inhibitors<br/>QTc-prolonging agents (indeterminate risk and risk modifying)</td><td class="align_center">Used for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Characteristics of sevoflurane using DTome.</div>

BioMed Research International

tab1

Table 1

Table 1: Autophagic Network Analysis of the Dual Effect of Sevoflurane on Neurons Associated with GABARAPL1 and 2 